• OptiMedica Corp. announced that is has been granted a patent relating to the technology underlying laser cataract surgery. The U.S. Patent & Trademark Office (USPTO) will issue the company a patent containing broad claims that describe a 3-D image-based femtosecond laser system for performing anterior capsulotomy and lens fragmentation during the cataract procedure.

    "We are gratified to see the USPTO recognize the novelty of our invention and its practical realization in OptiMedica's Catalys® Precision Laser System," said Dr. Mark Blumenkranz, professor and chairman of the department of ophthalmology at Stanford University, OptiMedica board member, and an inventor of the technology.

    The U.S. patent supporting Catalys is one in a series that OptiMedica has filed for the system and its underlying technology worldwide. These include five issued international patents, as well as more than 30 pending patents in the U.S. and more than 25 pending international patents.

    Catalys includes a femtosecond laser, integrated 3-D optical coherence tomography imaging, and pattern scanning technology.